Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
A Agilent Technologies	$121.16 +0.4%	$113.50	$96.43 ▼ $153.84	$34.28B	1.23	1.84 million shs	944,958 shs
CR Crane	$193.16 +0.4%	$175.67	$127.04 ▼ $194.06	$11.11B	1.26	283,615 shs	89,679 shs
DHR Danaher	$203.08 +0.3%	$195.52	$171.00 ▼ $281.70	$144.92B	0.77	3.50 million shs	1.39 million shs
RGEN Repligen	$127.36 +0.3%	$127.05	$102.97 ▼ $182.52	$7.13B	1.11	728,834 shs	208,766 shs

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
A Agilent Technologies	+0.17%	+1.22%	+7.45%	+17.66%	-3.94%
CR Crane	+0.28%	+2.66%	+10.60%	+40.90%	+33.54%
DHR Danaher	+0.29%	+0.59%	+5.71%	+11.94%	-15.46%
RGEN Repligen	+0.32%	+2.54%	+2.38%	+13.78%	+5.46%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
A Agilent Technologies	4.7465 of 5 stars	3.3	4.0	2.5	3.6	3.4	0.8	1.3
CR Crane	3.1451 of 5 stars	1.4	3.0	1.7	1.4	1.7	2.5	1.3
DHR Danaher	4.8853 of 5 stars	3.4	3.0	1.7	4.3	4.0	3.3	1.3
RGEN Repligen	4.817 of 5 stars	4.3	2.0	0.0	4.5	2.9	1.7	1.9

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
A Agilent Technologies	2.54	Moderate Buy	$140.92	16.32% Upside
CR Crane	2.75	Moderate Buy	$197.75	2.38% Upside
DHR Danaher	2.80	Moderate Buy	$248.61	22.42% Upside
RGEN Repligen	2.69	Moderate Buy	$172.83	35.70% Upside

Current Analyst Ratings Breakdown

Latest DHR, RGEN, A, and CR Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/24/2025	A Agilent Technologies	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Equal Weight ➝ Equal Weight	$115.00 ➝ $125.00
6/24/2025	DHR Danaher	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$215.00 ➝ $225.00
6/24/2025	RGEN Repligen	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Overweight	$150.00
6/10/2025	CR Crane	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$200.00
6/10/2025	CR Crane	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$187.00 ➝ $226.00
6/10/2025	CR Crane	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Buy ➝ Buy	$190.00 ➝ $215.00
6/5/2025	DHR Danaher	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target		$240.00 ➝ $235.00
5/30/2025	A Agilent Technologies	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy	$135.00
5/29/2025	A Agilent Technologies	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$150.00 ➝ $130.00
5/29/2025	A Agilent Technologies	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$160.00 ➝ $155.00
5/29/2025	A Agilent Technologies	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy	$150.00

(Data available from 7/4/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
A Agilent Technologies	$6.51B	5.29	$6.28 per share	19.30	$21.60 per share	5.61
CR Crane	$2.18B	5.10	$17.26 per share	11.19	$33.91 per share	5.70
DHR Danaher	$23.88B	6.09	$10.95 per share	18.54	$68.60 per share	2.96
RGEN Repligen	$634.44M	11.28	$3.12 per share	40.87	$35.21 per share	3.62

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
A Agilent Technologies	$1.29B	$4.05	29.91	19.93	3.66	17.59%	25.92%	13.24%	8/20/2025 (Estimated)
CR Crane	$401.10M	$5.77	25.58	22.54	1.93	13.10%	24.45%	10.14%	7/28/2025 (Confirmed)
DHR Danaher	$3.90B	$5.15	39.43	23.70	2.84	15.81%	10.80%	6.89%	7/22/2025 (Estimated)
RGEN Repligen	-$25.51M	-$0.45	N/A	53.97	3.63	-3.93%	4.53%	3.17%	7/29/2025 (Estimated)

Latest DHR, RGEN, A, and CR Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
7/29/2025	Q2 2025	RGEN Repligen	$0.40	N/A	N/A	N/A	$174.62 million	N/A
7/28/2025	Q2 2025	CR Crane	$1.33	N/A	N/A	N/A	$567.70 million	N/A
7/22/2025	Q2 2025	DHR Danaher	$1.64	N/A	N/A	N/A	$5.83 billion	N/A
5/28/2025	Q2 2025	A Agilent Technologies	$1.26	$1.31	+$0.05	$0.75	$1.63 billion	$1.67 billion
4/29/2025	Q1 2025	RGEN Repligen	$0.35	$0.39	+$0.04	$0.10	$163.65 million	$169.17 million
4/28/2025	Q1 2025	CR Crane	$1.29	$1.39	+$0.10	$1.83	$546.93 million	$557.60 million
4/22/2025	Q1 2025	DHR Danaher	$1.62	$1.88	+$0.26	$1.32	$5.58 billion	$5.74 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
A Agilent Technologies	$0.99	0.82%	N/A	24.44%	9 Years
CR Crane	$0.92	0.48%	N/A	15.94%	3 Years
DHR Danaher	$1.28	0.63%	N/A	24.85%	2 Years
RGEN Repligen	N/A	N/A	N/A	N/A	N/A

Latest DHR, RGEN, A, and CR Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/6/2025	DHR Danaher	quarterly	$0.32	0.67%		6/27/2025	7/25/2025
5/22/2025	A Agilent Technologies	quarterly	$0.2480	0.9%	7/1/2025	7/1/2025	7/23/2025
4/28/2025	CR Crane	quarterly	$0.23	0.62%	5/30/2025	5/30/2025	6/11/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
A Agilent Technologies	0.55	2.09	1.60
CR Crane	0.29	1.18	0.88
DHR Danaher	0.31	1.43	1.05
RGEN Repligen	0.27	6.79	5.79

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
A Agilent Technologies	N/A
CR Crane	75.14%
DHR Danaher	79.05%
RGEN Repligen	97.64%

Insider Ownership

Company	Insider Ownership
A Agilent Technologies	N/A
CR Crane	2.12%
DHR Danaher	11.10%
RGEN Repligen	1.20%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
A Agilent Technologies	17,900	284.07 million	N/A	Optionable
CR Crane	11,000	57.50 million	55.08 million	Optionable
DHR Danaher	63,000	715.67 million	636.23 million	Optionable
RGEN Repligen	1,778	56.18 million	55.51 million	Optionable

DHR, RGEN, A, and CR Headlines

Recent News About These Companies

1 Healthcare Stock to Target This Week and 2 to Be Wary Of

July 3 at 6:45 PM | msn.com

WCM Investment Management LLC Has $13.74 Million Stock Position in Repligen Corporation (NASDAQ:RGEN)

July 3 at 5:38 AM | marketbeat.com

Mirae Asset Global Investments Co. Ltd. Has $3.98 Million Stake in Repligen Corporation (NASDAQ:RGEN)

July 2 at 4:31 AM | marketbeat.com

Allspring Global Investments Holdings LLC Purchases 16,421 Shares of Repligen Corporation (NASDAQ:RGEN)

June 30, 2025 | marketbeat.com

Repligen (NASDAQ:RGEN) Downgraded by Wall Street Zen to "Hold"

June 30, 2025 | americanbankingnews.com

Wall Street Zen Downgrades Repligen (NASDAQ:RGEN) to Hold

June 29, 2025 | marketbeat.com

Artemis Investment Management LLP Grows Position in Repligen Corporation (NASDAQ:RGEN)

June 27, 2025 | marketbeat.com

Oppenheimer Asset Management Inc. Boosts Position in Repligen Corporation (NASDAQ:RGEN)

June 27, 2025 | marketbeat.com

Bessemer Group Inc. Buys 4,325 Shares of Repligen Corporation (NASDAQ:RGEN)

June 26, 2025 | marketbeat.com

Repligen (NASDAQ:RGEN) Coverage Initiated at Barclays

June 26, 2025 | americanbankingnews.com

5 Insightful Analyst Questions From Repligen’s Q1 Earnings Call

June 25, 2025 | msn.com

Wealthquest Corp Takes Position in Repligen Corporation (NASDAQ:RGEN)

June 25, 2025 | marketbeat.com

Barclays Initiates Coverage of Repligen (RGEN) with Overweight Recommendation

June 24, 2025 | msn.com

Repligen (NASDAQ:RGEN) Earns Overweight Rating from Analysts at Barclays

June 24, 2025 | marketbeat.com

Repligen (NASDAQ:RGEN) Raised to Buy at Wall Street Zen

June 21, 2025 | marketbeat.com

Repligen Corporation (NASDAQ:RGEN) Shares Sold by Riverbridge Partners LLC

June 20, 2025 | marketbeat.com

Conestoga Capital Advisors LLC Purchases 32,665 Shares of Repligen Co. (NASDAQ:RGEN)

June 17, 2025 | marketbeat.com

Trust Point Inc. Trims Holdings in Repligen Co. (NASDAQ:RGEN)

June 17, 2025 | marketbeat.com

Repligen (NASDAQ:RGEN) Shares Down 3.1% - Should You Sell?

June 16, 2025 | marketbeat.com

Azzad Asset Management Inc. ADV Acquires Shares of 21,077 Repligen Co. (NASDAQ:RGEN)

June 15, 2025 | marketbeat.com

Does Repligen Corp (RGEN) Have a Strong Pricing Power?

June 13, 2025 | insidermonkey.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

Why BigBear.ai Could Rally 100% and Catch Palantir Soon
By Gabriel Osorio-Mazilli | June 30, 2025
View Why BigBear.ai Could Rally 100% and Catch Palantir Soon
IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge
By Dan Schmidt | June 20, 2025
View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge
BigBear.ai Poised to Benefit as Palantir Dominates AI Defense
By Gabriel Osorio-Mazilli | June 23, 2025
View BigBear.ai Poised to Benefit as Palantir Dominates AI Defense
Intel's Turnaround Strategy Shifts From Planning to Attack Mode
By Jeffrey Neal Johnson | June 20, 2025
View Intel's Turnaround Strategy Shifts From Planning to Attack Mode
3 Semiconductor Stocks Poised to Surge on AI Spending
By Chris Markoch | June 25, 2025
View 3 Semiconductor Stocks Poised to Surge on AI Spending

DHR, RGEN, A, and CR Company Descriptions

Agilent Technologies NYSE:A

$121.16 +0.50 (+0.41%)

Closing price 07/3/2025 03:46 PM Eastern

Extended Trading

$121.16 0.00 (0.00%)

As of 07/3/2025 04:20 PM Eastern

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Crane NYSE:CR

$193.16 +0.74 (+0.38%)

Closing price 07/3/2025 03:30 PM Eastern

Extended Trading

$193.26 +0.09 (+0.05%)

As of 07/3/2025 04:59 PM Eastern

Crane Company, together with its subsidiaries, manufactures and sells engineered industrial products in the United States, Canada, the United Kingdom, Continental Europe, and internationally. The company operates in three segments: Aerospace & Electronics, Process Flow Technologies, and Engineered Materials. The Aerospace & Electronics segment supplies critical components and systems, including original equipment and aftermarket parts for commercial aerospace, as well as the military aerospace, defense, and space markets. This segment also offers pressure sensors for aircraft engine control, aircraft braking systems for commercial aircraft and fighter jets, power conversion solutions for spacecraft, and lubrication systems. The Process Flow Technologies segment provides engineered fluid handling equipment for mission-critical applications. It offers process valves and related products, such as lined pipe, fittings and hoses, air-operated diaphragm and peristaltic pumps, instrumentation and sampling systems, valve positioning and control systems, and valve diagnostic and calibration systems; commercial valves; and pumps and systems. The Engineered Materials segment manufactures fiberglass-reinforced plastic panels and coils for use in the manufacturing of recreational vehicles, as well as in commercial and industrial building applications. This segment sells directly to RV, trailer, and truck manufacturers, as well as through distributors and retailers. The company provides its products and solutions to end markets, including commercial and military aerospace, defense, and space; chemical and pharmaceutical production; water and wastewater; non-residential and municipal construction; energy; and other general industrial and consumer-related applications. The company was formerly known as Crane Holdings, Co. Crane Company was founded in 1855 and is based in Stamford, Connecticut.

Danaher NYSE:DHR

$203.08 +0.58 (+0.28%)

Closing price 07/3/2025 03:43 PM Eastern

Extended Trading

$205.48 +2.41 (+1.19%)

As of 07/3/2025 04:50 PM Eastern

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.

Repligen NASDAQ:RGEN

$127.36 +0.40 (+0.32%)

Closing price 07/3/2025 01:10 PM Eastern

Extended Trading

$127.36 0.00 (0.00%)

As of 07/3/2025 04:03 PM Eastern

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time